ARTICLE | Clinical News
Clenoliximab (IDEC-151/SB-217969): Update
October 25, 1999 7:00 AM UTC
Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif. Product: Clenoliximab (IDEC-151/SB-217969) Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: CD4 Description: Primatized an...